Explicit content
The Therapeutic Goods Administration (TGA) is Australia's regulatory authority for therapeutic goods, ensuring that products such as medicines, medical devices, and biologicals are safe, effective, and of high quality. The TGA provides comprehensive information regarding the approval processes, regulatory frameworks, and guidelines that govern the use of these products within Australia. Through its user-friendly online platform, the TGA facilitates easy access to essential resources, including detailed product information, safety updates, and advisory notifications, aiming to protect and promote public health.
The TGA also plays a pivotal role in monitoring the safety of therapeutic goods post-approval, conducting thorough assessments, and responding to any emerging health issues related to the products they oversee. By engaging with healthcare professionals, industry stakeholders, and the general public, the TGA ensures open communication regarding health risks and product recalls. The website serves as a valuable tool for consumers and healthcare providers alike, offering guidance and support when navigating the therapeutic landscape in Australia.
In addition, the TGA is committed to transparency and accountability, providing access to research findings and regulatory decisions. This fosters trust and confidence in the health systems and products that Australians rely on. Their ongoing collaborations with international regulatory bodies exemplify their dedication to harmonizing standards and practices globally, ensuring that Australian citizens benefit from the latest advancements in healthcare while maintaining high safety standards.
Rank by traffic
In June 2025, tga.gov.au saw a decrease in search traffic, reaching 406K visits, which is a decrease of 11K visits compared to the previous month. The traffic value increased to 324K, a growth of 27K.
For tga.gov.au, Australia dominates traffic with 213K visits, an increase of 7.8K from the previous month, making up 52.5% of the total traffic.
Location | Traffic | Share | |||||||
---|---|---|---|---|---|---|---|---|---|
213K | +7.8K | 52.5% | |||||||
78K | −127 | 19.2% | |||||||
33K | −2.1K | 8.3% | |||||||
27K | −266 | 6.6% | |||||||
14K | +1.8K | 3.6% | |||||||
tga.gov.au ranks #1 for "ozempic shortage" in United States and receives 3.9K monthly visits from this keyword alone, an increase of 648 from the previous month.
Keyword | Volume | Traffic | Position | ||||||
---|---|---|---|---|---|---|---|---|---|
ozempic shortage | 8.9K | 3.9K | +648 | 1 | |||||
vyvanse shortage | 23K | −1.0K | 3.4K | +1.4K | 5 → 3 | ||||
tga | 9.1K | −300 | 2.0K | −54 | 1 | ||||
amox-clav 875-125 | 2.9K | +2.9K | 1.7K | +1.7K | 1 | ||||
trulicity shortage | 11K | 1.3K | +47 | 3 | |||||
nps.org.au, pbs.gov.au and medsafe.govt.nz rank in the top 10 organic search results for the same keywords that tga.gov.au gets the most traffic from. Discover more competitors of tga.gov.au.
Website | Traffic | Pages | |||||||
---|---|---|---|---|---|---|---|---|---|
nps.org.au | 1.2M | 8.6K | |||||||
pbs.gov.au | 38K | 7.0K | |||||||
medsafe.govt.nz | 1.0M | 3.6K | |||||||
medicines.org.uk | 3.8M | 7.3K | |||||||
medsinfo.com.au | 22K | 3.1K | |||||||
As of June 2025, tga.gov.au's Domain Rating is 84. tga.gov.au is linked by 19K websites, indicating a decrease of 86 referring sites from the previous month.
Get an in-depth look at the organic search traffic and backlink profile of any website or URL.